Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
Sidse Kjærhus Nørgaard, Julie Carstens Søholm, Elisabeth R. Mathiesen, Kirsten Nørgaard, Tine D. Clausen, Pernille Holmager, Nicoline Callesen, Peter Damm, Lene Ringholm
Topics & Concepts
MedicineInsulin aspartType 2 diabetesOpen labelPregnancyInsulinType 1 diabetesRandomized controlled trialInternal medicineDiabetes mellitusEndocrinologyGeneticsBiologyGestational Diabetes Research and ManagementBreastfeeding Practices and InfluencesHyperglycemia and glycemic control in critically ill and hospitalized patients